---
layout: news-article
title: Small RNA Molecule in Blood Could Help Diagnose Pancreatic Cancer
meta: Indiana University cancer researcher has demonstrated that a particular molecule is present in the blood of most pancreatic cancer patients, suggesting it could someday be a diagnostic marker for the disease.
source: http://www.sciencedaily.com/releases/2013/11/131107142434.htm
category: traits
---


Nov. 7, 2013 â€” An Indiana University cancer researcher has demonstrated that a particular molecule is present in the blood of most pancreatic cancer patients, suggesting it could someday be a diagnostic marker for the disease.
Share This:



In research published recently in the journal Oncogene, Murray Korc, M.D., the Myles Brand Professor of Cancer Research at the Indiana University School of Medicine and a researcher at the Indiana University Melvin and Bren Simon Cancer Center, showed that an RNA molecule -- microRNA-10b, or miR-10b -- is present at high levels in the blood of most pancreatic cancer patients. Consequently, miR-10b could serve as a diagnostic marker as well as help physicians determine the disease's aggressiveness.
Such a marker would be an advance against pancreatic cancer because current treatments typically only extend a person's life for six to 10 weeks. Pancreatic cancer is difficult to detect and diagnose because there are no noticeable signs or symptoms in the early stages and because the pancreas is hidden behind other organs such as the stomach, small intestine, liver, gallbladder, spleen and bile ducts.